Cardiovascular Diseases: From Molecular Pharmacology to Evidence–Based Therapeutics

Even though there has been improvement in treatment and significant reduction in mortality rate, cardiovascular disease remains one of the leading causes of death around the world. Drug therapy continues to rank high as a way to manage heart disease – making cardiovascular pharmacology a key part of medical education and drug development research. This book addresses the needs of these students and researchers by systematically integrating essentials, advances, and clinical correlations for cardiovascular drugs. The author, who has over two decades of experience teaching this topic, covers both the fundamentals and most recent advances in the pharmacology of cardiovascular drugs, as well as their integrated applications in the management of individual cardiovascular diseases. In addition, the text presents evidence–based pharmacotherapeutics in the management of common cardiovascular diseases and conditions that include dyslipidemias, hypertension, ischemic heart disease, heart failure, cardiac arrhythmias, and ischemic stroke. Written in an accessible style and consistent format, the book covers both the fundamentals and advances in the pharmacology of cardiovascular drugs, as well as their integrated applications in the management of individual cardiovascular diseases. •    Blends basic and clinical sciences needed to effectively understand and treat cardiovascular diseases •    Facilitates understanding of drug action and mechanism by covering physiology / pathophysiology and pharmacology •    Includes guidelines and algorithms for pharmacotherapeutic management of cardiovascular diseases •    Uses case presentations and study questions to enhance understanding of the material •    Serves as a resource for pharmaceutical and medical students and researchers interested in cardiovascular issues

Y. Robert Li is Professor and Founding Chair of the Department of Pharmacology and Assistant Dean for Biomedical Research at Campbell University and holds Adjunct Professor appointments at Virginia Tech–Wake Forest University School of Biomedical Engineering and Sciences, Virginia–Maryland Regional College of Veterinary Medicine, and University of North Carolina at Greensboro. He is an author of over 110 peer–reviewed publications, three monographs, and numerous book chapters and serves on the editorial boards of several leading journals. Dr. Li has over 20 years of teaching experience in the areas of biomedical sciences, free radical biology, toxicology, pharmacology, and therapeutics.